Getting drugs and devices to the doorstep is only half the battle. When digital connections fail, trials fail. Why the digital last mile needs clinical supply ownership, human-centered design, and tech support with a bedside manner.
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How Data Collection Is Enabling CROs To Expand Service Offerings
Explore how innovative processes and advanced data collection technologies like ePRO and eCOA can help contract research organizations expand their service offerings.
-
The Catch-22 Of eConsent: A Missed Opportunity For Improved Trials
Drawing on evidence from scientific literature, we examine the pitfalls that have hindered its success and propose actionable solutions to unlock its true value in clinical research.
-
eCOA Evolution: Have We Overcomplicated It?
eCOA has evolved from simple data collection to complex patient engagement platforms, raising concerns about added complexity. Explore innovative tools aimed at simplifying this complexity.
-
How Wearable Devices Improve Patient Engagement In Clinical Trials
Wearables are no longer optional—they are foundational to the future of patient-centric, data-driven clinical research.
-
Remote Clinical Trial Monitoring: CRA Success In An Era Of Autonomy
As organizations become more skillful in training and monitoring CRAs, the latter can be empowered with greater flexibility and freedom in scheduling and travel.
-
Beyond The Pandemic: Why eCOAs Are Here To Stay
The permanent adoption of eCOA is a natural step in the industry-wide effort to create a more patient-centric clinical trial experience. Learn more in the available blog.
-
Driving Successful Obesity Drug Development With GLP-1 Agonists
GLP-1 agonists are revolutionizing obesity treatment. Signant Health's ePRO solutions support over 30 trials, providing critical patient data and driving successful approvals.
-
Do We Still Need Patients In Tomorrow's Trials?
Delve into how advanced technologies reshape drug development and patient care, and the crucial balance needed between innovation and ethical responsibility to achieve better trial outcomes.
-
An Expert's View On Choosing And Developing An eCOA Strategy
Dive into the insights from our recent LinkedIn Live discussion where we explored how a standardized approach to eCOA could transform clinical trials and streamline data collection.
-
What Does EDC Look Like In 2024 And Beyond?
Read along as industry experts from TrialKit offer insights into the anticipated developments and challenges surrounding electronic data capture.